What changed in R2026.15 (package 1.14.0, 2026-10-01)
39,798
sample × field values added (19,899 samples, 117 studies)
0
catalog studies added
0
registry studies added
Values added, by field
| field | values | samples | studies |
|---|---|---|---|
| intervention | 19,899 | 19,899 | 117 |
| intervention_detail | 19,899 | 19,899 | 117 |
By route: R1 39,798
Studies with the most added values
| study | title | values | samples touched | samples in study | fields | routes |
|---|---|---|---|---|---|---|
| PRJEB28097 | (1) Personalized microbiome and host features resist gut mucosal colonization by empiric probiotics | 3,002 | 1,501 | 1,613 | intervention, intervention_detail | R1 |
| PRJNA594610 | Human gut microbiome response to PDX intake | 1,944 | 972 | 972 | intervention, intervention_detail | R1 |
| PRJNA594393 | Human gut microbiome response to FOS intake | 1,894 | 947 | 947 | intervention, intervention_detail | R1 |
| PRJNA797994 | Gut Microbiome of Helminth Infected Indigenous Malaysians Is Context Dependent | 1,300 | 650 | 650 | intervention, intervention_detail | R1 |
| PRJNA1086951 | MIND Study - Fecal Metagenomics | 1,276 | 638 | 638 | intervention, intervention_detail | R1 |
| PRJNA594620 | Human gut microbiome response to PDX intake followed by FOS intake | 1,122 | 561 | 561 | intervention, intervention_detail | R1 |
| PRJEB105465 | Effects of antibiotic treatment on normal intestinal flora (ARG-study) | 1,094 | 547 | 548 | intervention, intervention_detail | R1 |
| PRJNA594613 | Human gut microbiome response to FOS intake followed by PDX intake | 982 | 491 | 491 | intervention, intervention_detail | R1 |
| PRJNA1258884 | Impact of Yogurt and Rolled Oats on the Gut Microbiome: A Randomized Crossover Study displaying Indi | 880 | 440 | 440 | intervention, intervention_detail | R1 |
| PRJNA675301 | Role of Diet in the Reconstitution of the Human Gut Microbiome and its Metabolome | 868 | 434 | 474 | intervention, intervention_detail | R1 |
| PRJNA804384 | Inflammatory bowel disease patients undergoing biological therapy | 864 | 432 | 432 | intervention, intervention_detail | R1 |
| PRJNA637785 | Multi-donor FMT to treat adolescents with severe obesity (The Gut Bugs Trial) | 858 | 429 | 430 | intervention, intervention_detail | R1 |
| PRJEB56830 | Isocaloric dietary protein intervention | 850 | 425 | 430 | intervention, intervention_detail | R1 |
| PRJNA1249224 | Metagenomic Illumina and Nanopore sequencing data of MAC study cohort | 816 | 408 | 408 | intervention, intervention_detail | R1 |
| PRJNA904651 | Multiomic analysis of microbiome and host identifies features differentiating diet and surgical indu | 796 | 398 | 408 | intervention, intervention_detail | R1 |
| PRJNA1220341 | Human gut microbiome during treatment with CRISPR-armed phages (SNIPR001) or placebo | 782 | 391 | 391 | intervention, intervention_detail | R1 |
| PRJNA728374 | Gut microbiome responses to dietary intervention with hypocholesterolemic vegetable oils. | 756 | 378 | 378 | intervention, intervention_detail | R1 |
| SRP057027 | Inflammation, Antibiotics, and Diet as Concurrent Environmental Stressors of the Gut Microbiome in P | 686 | 343 | 369 | intervention, intervention_detail | R1 |
| PRJNA1402699 | Dietary resistant starches type 2 and 4 differentially impact the human gut microbiome | 682 | 341 | 341 | intervention, intervention_detail | R1 |
| PRJNA922086 | Deleterious impact of beta-lactam antibiotics on intestinal microbiome of human healthy volunteers a | 670 | 335 | 335 | intervention, intervention_detail | R1 |
| PRJNA1056456 | Homo sapiens Metagenome | 654 | 327 | 327 | intervention, intervention_detail | R1 |
| PRJNA1356862 | Geographic spillover of antimicrobial resistance from mass distribution of azithromycin | 632 | 316 | 630 | intervention, intervention_detail | R1 |
| PRJNA854889 | A Randomized Trial Comparing the Specific Carbohydrate Diet to a Mediterranean Diet in Adults With C | 626 | 313 | 339 | intervention, intervention_detail | R1 |
| PRJEB58157 | Perturbation and resilience of the gut microbiome three months after β-lactams exposure in healthy v | 554 | 277 | 277 | intervention, intervention_detail | R1 |
| PRJNA1463324 | VE202 phase 1 stool metagenomes | 546 | 273 | 273 | intervention, intervention_detail | R1 |